Functional Endoscopic Sinus Surgery Market by Product (Endoscopes (Sinuscopes, Rhinoscopes), Surgical Instruments, Navigation Systems), Procedure (Maxillary, Ethmoid), Indication (Chronic Sinusitis, Nasal Polyposis), Patient type - Global Forecast to 2029
The global Functional endoscopic sinus surgery market is projected to reach USD 1.7 billion by 2029 from USD 1.2 billion in 2024, at a CAGR of 7.6% during the forecast period. The growth of this market is majorly driven by rise in demand for minimally invasive surgeries, growing awareness about the disease, and technological advancements. The emergence of AI have changed the scenario in FESS due to which large amount of data could be analysed including patient records, treatment outcomes, so that valuable insights could be drawn and will help in decision making. Thus, due to integrating innovative techniques and individualized treatment methods, patient outcomes have significantly improved in FESS. However, associated risks due to surgeries will restrain the FESS market during the forecast period.
“Surgical instruments segment accounted for the highest market share in the Functional endoscopic sinus surgery market, by product, during the forecast period.”
The functional endoscopic sinus surgery market, by product, is segmented into endoscopes, surgical instruments, and navigation systems. The surgical instruments segment accounted for the largest market share in 2023. The growth in specialized ENT and endoscopic sinus surgery centers is increasing the demand for dedicated surgical instruments used in FESS and frequent updates and product launches in surgical instruments technology.
“Maxillary sinus surgery accounted for the larger market share in the Functional endoscopic sinus surgery market, by procedure, during the forecast period.”
Based on procedure, the functional endoscopic sinus surgery market is segmented into frontal sinus surgery, ethmoid sinus surgery, maxillary sinus surgery, sphenoid sinus surgery, and other procedures. The maxillary sinus surgery segment accounted for the largest market share in 2023. The large share of this segment can be attributed due to the rise in number of maxillary sinus surgeries, growing awareness, advancements in technologies, and patient demand.
“Hospitals & ASCs accounted for the highest CAGR during the forecast period.”
Based on the end user, the Functional endoscopic sinus surgery market is segmented into hospitals & ASCs, and specialty clinics. The hospitals & ASCs segment accounted for the largest share of the functional endoscopic sinus surgery market in 2023. Large number of sinus surgeries being performed in ASCs, growing investments in healthcare infrastructure and facilities are supporting the growth of this end-user segment.
“The North America segment accounted for the highest market share in the Functional endoscopic sinus surgery market, by region, during the forecast period.”
Based on the region, the Functional endoscopic sinus surgery market is divided into North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC. North America region accounted for the largest share of the global Functional endoscopic sinus surgery market in 2023. This large share of North America is due to the strong healthcare system, presence of leading players, and innovation in technologies such as navigation systems and endoscopes.
Breakdown of supply-side primary interviews by company type, designation, and region:
Research Coverage
This research report categorizes the Functional endoscopic sinus surgery market by product, procedure, indication, patient type, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Functional endoscopic sinus surgery market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the Functional endoscopic sinus surgery market. Competitive analysis of upcoming startups in the Functional endoscopic sinus surgery market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Functional endoscopic sinus surgery market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
“Surgical instruments segment accounted for the highest market share in the Functional endoscopic sinus surgery market, by product, during the forecast period.”
The functional endoscopic sinus surgery market, by product, is segmented into endoscopes, surgical instruments, and navigation systems. The surgical instruments segment accounted for the largest market share in 2023. The growth in specialized ENT and endoscopic sinus surgery centers is increasing the demand for dedicated surgical instruments used in FESS and frequent updates and product launches in surgical instruments technology.
“Maxillary sinus surgery accounted for the larger market share in the Functional endoscopic sinus surgery market, by procedure, during the forecast period.”
Based on procedure, the functional endoscopic sinus surgery market is segmented into frontal sinus surgery, ethmoid sinus surgery, maxillary sinus surgery, sphenoid sinus surgery, and other procedures. The maxillary sinus surgery segment accounted for the largest market share in 2023. The large share of this segment can be attributed due to the rise in number of maxillary sinus surgeries, growing awareness, advancements in technologies, and patient demand.
“Hospitals & ASCs accounted for the highest CAGR during the forecast period.”
Based on the end user, the Functional endoscopic sinus surgery market is segmented into hospitals & ASCs, and specialty clinics. The hospitals & ASCs segment accounted for the largest share of the functional endoscopic sinus surgery market in 2023. Large number of sinus surgeries being performed in ASCs, growing investments in healthcare infrastructure and facilities are supporting the growth of this end-user segment.
“The North America segment accounted for the highest market share in the Functional endoscopic sinus surgery market, by region, during the forecast period.”
Based on the region, the Functional endoscopic sinus surgery market is divided into North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC. North America region accounted for the largest share of the global Functional endoscopic sinus surgery market in 2023. This large share of North America is due to the strong healthcare system, presence of leading players, and innovation in technologies such as navigation systems and endoscopes.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
- By Designation: C-level (30%), Director-level (20%), and Others (50%)
- By Region: North America (34%), Asia- Pacific (27%), Europe (23%), Latin America- (7%) and MEA-(5%), and GCC (4%).
Research Coverage
This research report categorizes the Functional endoscopic sinus surgery market by product, procedure, indication, patient type, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Functional endoscopic sinus surgery market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the Functional endoscopic sinus surgery market. Competitive analysis of upcoming startups in the Functional endoscopic sinus surgery market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Functional endoscopic sinus surgery market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (high prevalence of chronic sinusitis, growing preference for MIS, technological advancements, and rising awareness), restraints (risks involved in surgeries, the availability of nonsurgical treatments, and high procedural costs), opportunities (integration of AI and robotics in FESS and growing healthcare market in emerging economics), and challenges (shortage of skilled surgeons) influencing the growth of the Functional endoscopic sinus surgery market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Functional endoscopic sinus surgery market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the Functional endoscopic sinus surgery market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Functional endoscopic sinus surgery market
- Competitive Assessment: In-depth assessment of market ranking, growth strategies, and product offerings of leading players like Medtronic plc (Ireland), Stryker Corporation (US), Olympus Corporation (Japan), B. Braun Melsungen Ag (Germany), KARL STORZ (Germany), among others in the Functional endoscopic sinus surgery market strategies.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primary interviews
2.1.2.2 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: BOTTOM-UP APPROACH
2.2.1.1 Growth forecast
2.2.2 TOP-DOWN APPROACH
2.2.3 GEOGRAPHIC MARKET ASSESSMENT
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET OVERVIEW
4.2 ASIA PACIFIC: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PROCEDURE (2023)
4.3 REGIONAL GROWTH OPPORTUNITIES IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET
4.4 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: REGIONAL MIX
4.5 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High prevalence of chronic sinusitis
5.2.1.2 Growing preference for MIS
5.2.1.3 Technological advancements
5.2.1.4 Rising awareness
5.2.2 RESTRAINTS
5.2.2.1 Risks associated with sinus surgeries
5.2.2.2 Availability of nonsurgical treatments for chronic sinusitis
5.2.2.3 High procedural costs
5.2.3 OPPORTUNITIES
5.2.3.1 Integration of AI and robotics in FESS
5.2.3.2 Growing healthcare market in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals
5.2.5 TRENDS
5.2.5.1 Emergence of minimally invasive in-office sinus surgery
5.2.5.2 Increased use of artificial intelligence (AI)
5.2.5.3 Development of new surgical techniques
5.2.5.4 Personalized treatment plans
5.2.5.5 Improved patient outcomes
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND OF FESS PRODUCTS
5.3.2 AVERAGE SELLING PRICE OF FESS PRODUCTS, BY REGION
5.4 PATENT ANALYSIS
5.4.1 LIST OF MAJOR PATENTS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.7.1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.9.2 BUYING CRITERIA
5.1 REGULATORY ANALYSIS
5.10.1 REGULATORY LANDSCAPE
5.10.1.1 US
5.10.1.2 Europe
5.10.1.3 India
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TRADE ANALYSIS
5.12 TECHNOLOGY ANALYSIS
5.12.1 KEY TECHNOLOGIES
5.12.1.1 Endoscopes
5.12.1.2 Navigation systems
5.12.2 ADJACENT TECHNOLOGIES
5.12.2.1 Balloon sinus dilation devices
5.13 KEY CONFERENCES AND EVENTS IN 2024–2025
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.15 INVESTMENT AND FUNDING SCENARIO
5.16 IMPACT OF GENERATIVE AI ON FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET
6 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SURGICAL INSTRUMENTS
6.2.1 SURGICAL INSTRUMENTS TO HOLD LARGEST MARKET SHARE
6.3 ENDOSCOPES
6.3.1 SINUSCOPES
6.3.1.1 Sinuscopes to hold largest share of FESS endoscopes market
6.3.2 RHINOSCOPES
6.3.2.1 Greater flexibility over sinuscopes to support market growth
6.4 NAVIGATION SYSTEMS
6.4.1 OPTICAL NAVIGATION SYSTEMS
6.4.2 ELECTROMAGNETIC NAVIGATION SYSTEMS
6.4.2.1 Advantageous over optical navigation systems to drive market
7 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PROCEDURE
7.1 INTRODUCTION
7.2 MAXILLARY SINUS SURGERY
7.2.1 INVASIVE NATURE TO AFFECT ADOPTION OF MAXILLARY SINUS SURGERY
7.3 ETHMOID SINUS SURGERY
7.3.1 EFFECTIVENESS OF TREATMENT TO DRIVE ADOPTION
7.4 FRONTAL SINUS SURGERY
7.4.1 INCREASING PREVALENCE OF CHRONIC RHINOSINUSITIS TO DRIVE MARKET
7.5 SPHENOID SINUS SURGERY
7.5.1 HIGHER INDICATIONS FOR SURGERY TO BOOST ADOPTION
7.6 OTHER PROCEDURES
8 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY INDICATION
8.1 INTRODUCTION
8.2 FUNGAL SINUSITIS
8.2.1 RISING EXPOSURE TO FUNGAL SPORES TO DRIVE MARKET
8.3 CHRONIC SINUSITIS
8.3.1 GROWING PREVALENCE OF CRS TO SUPPORT MARKET GROWTH
8.4 NASAL POLYPOSIS
8.4.1 WIDE PREVALENCE OF CAUSATIVE/CONTRIBUTING FACTORS TO DRIVE MARKET
8.5 RECURRENT SINUSITIS
8.5.1 GROWING PREVALENCE OF COLD TO SUPPORT MARKET GROWTH
8.6 OTHER INDICATIONS
9 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PATIENT TYPE
9.1 INTRODUCTION
9.2 ADULT PATIENTS
9.2.1 ADULT PATIENTS TO DOMINATE MARKET FOR FESS
9.3 PEDIATRIC PATIENTS
9.3.1 HIGH PREVALENCE OF SINUSITIS IN CHILDREN TO DRIVE MARKET
10 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS & AMBULATORY SURGERY CENTERS
10.2.1 HOSPITALS & ASCS TO FORM LARGEST AND FASTEST-GROWING END-USER SEGMENT
10.3 SPECIALTY CLINICS
10.3.1 FASTER RECOVERY TIME AND COST-EFFECTIVENESS TO SUPPORT GROWTH
11 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US to dominate North American market
11.2.2 CANADA
11.2.2.1 Rising geriatric population and associated increase in prevalence of CRS to support market growth
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Germany to hold largest market share in Europe
11.3.2 UK
11.3.2.1 High R&D expenditure to drive market
11.3.3 FRANCE
11.3.3.1 High burden of chronic sinusitis to propel adoption of FESS
11.3.4 ITALY
11.3.4.1 Growing geriatric population to support adoption of FESS products
11.3.5 SPAIN
11.3.5.1 Rising healthcare expenditure to drive market for FESS
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 China to hold largest market share in APAC
11.4.2 JAPAN
11.4.2.1 Research initiatives to support market growth in Japan
11.4.3 INDIA
11.4.3.1 Increasing investments in research to support market growth
11.4.4 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 BRAZIL
11.5.1.1 Brazil to hold largest share of LATAM market till 2029
11.5.2 MEXICO
11.5.2.1 Rising geriatric population to support market growth
11.5.3 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 RISING HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH
11.7 GCC COUNTRIES
11.7.1 UAE
11.7.1.1 Growing number of hospitals to drive market
11.7.2 SAUDI ARABIA
11.7.2.1 Healthcare infrastructural improvements to support market growth
11.7.3 OTHER GCC COUNTRIES
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET
12.3 REVENUE ANALYSIS
12.4 MARKET SHARE ANALYSIS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Product footprint
12.5.5.3 Regional footprint
12.5.5.4 Procedure footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 VALUATION & FINANCIAL METRICS
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 MEDTRONIC PLC
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Deals
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 STRYKER CORPORATION
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 OLYMPUS CORPORATION
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product approvals
13.1.3.4 MnM view
13.1.3.4.1 Right to win
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses & competitive threats
13.1.4 B. BRAUN MELSUNGEN AG
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.5 KARL STORZ
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.6 CONMED CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.7 TELEFLEX INCORPORATED
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.8 INTEGRA LIFESCIENCES
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Deals
13.1.9 BRAINLAB AG
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 RUDOLF MEDICAL GMBH + CO. KG
13.1.10.1 Business overview
13.1.10.2 Products offered
13.2 OTHER PLAYERS
13.2.1 ATMOS MEDIZINTECHNIK
13.2.2 INNOVIA MEDICAL
13.2.3 SUTTER MEDIZINTECHNIK GMBH
13.2.4 RZ MEDIZINTECHNIK
13.2.5 ADVIN HEALTHCARE
13.2.6 ECLERIS
13.2.7 HENKE SASS WOLF
13.2.8 JEDMED
13.2.9 ENTERMED
13.2.10 FIAGON GMBH
13.2.11 CLARONAV KOLAHI INC.
13.2.12 ADEPT MEDICAL
13.2.13 MEDELEC SURGICAL
13.2.14 HEAL FORCE BIO-MEDITECH HOLDINGS LIMITED
13.2.15 COLLIN MEDICAL
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primary interviews
2.1.2.2 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: BOTTOM-UP APPROACH
2.2.1.1 Growth forecast
2.2.2 TOP-DOWN APPROACH
2.2.3 GEOGRAPHIC MARKET ASSESSMENT
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET OVERVIEW
4.2 ASIA PACIFIC: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PROCEDURE (2023)
4.3 REGIONAL GROWTH OPPORTUNITIES IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET
4.4 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: REGIONAL MIX
4.5 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High prevalence of chronic sinusitis
5.2.1.2 Growing preference for MIS
5.2.1.3 Technological advancements
5.2.1.4 Rising awareness
5.2.2 RESTRAINTS
5.2.2.1 Risks associated with sinus surgeries
5.2.2.2 Availability of nonsurgical treatments for chronic sinusitis
5.2.2.3 High procedural costs
5.2.3 OPPORTUNITIES
5.2.3.1 Integration of AI and robotics in FESS
5.2.3.2 Growing healthcare market in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals
5.2.5 TRENDS
5.2.5.1 Emergence of minimally invasive in-office sinus surgery
5.2.5.2 Increased use of artificial intelligence (AI)
5.2.5.3 Development of new surgical techniques
5.2.5.4 Personalized treatment plans
5.2.5.5 Improved patient outcomes
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND OF FESS PRODUCTS
5.3.2 AVERAGE SELLING PRICE OF FESS PRODUCTS, BY REGION
5.4 PATENT ANALYSIS
5.4.1 LIST OF MAJOR PATENTS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.7.1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.9.2 BUYING CRITERIA
5.1 REGULATORY ANALYSIS
5.10.1 REGULATORY LANDSCAPE
5.10.1.1 US
5.10.1.2 Europe
5.10.1.3 India
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TRADE ANALYSIS
5.12 TECHNOLOGY ANALYSIS
5.12.1 KEY TECHNOLOGIES
5.12.1.1 Endoscopes
5.12.1.2 Navigation systems
5.12.2 ADJACENT TECHNOLOGIES
5.12.2.1 Balloon sinus dilation devices
5.13 KEY CONFERENCES AND EVENTS IN 2024–2025
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.15 INVESTMENT AND FUNDING SCENARIO
5.16 IMPACT OF GENERATIVE AI ON FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET
6 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SURGICAL INSTRUMENTS
6.2.1 SURGICAL INSTRUMENTS TO HOLD LARGEST MARKET SHARE
6.3 ENDOSCOPES
6.3.1 SINUSCOPES
6.3.1.1 Sinuscopes to hold largest share of FESS endoscopes market
6.3.2 RHINOSCOPES
6.3.2.1 Greater flexibility over sinuscopes to support market growth
6.4 NAVIGATION SYSTEMS
6.4.1 OPTICAL NAVIGATION SYSTEMS
6.4.2 ELECTROMAGNETIC NAVIGATION SYSTEMS
6.4.2.1 Advantageous over optical navigation systems to drive market
7 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PROCEDURE
7.1 INTRODUCTION
7.2 MAXILLARY SINUS SURGERY
7.2.1 INVASIVE NATURE TO AFFECT ADOPTION OF MAXILLARY SINUS SURGERY
7.3 ETHMOID SINUS SURGERY
7.3.1 EFFECTIVENESS OF TREATMENT TO DRIVE ADOPTION
7.4 FRONTAL SINUS SURGERY
7.4.1 INCREASING PREVALENCE OF CHRONIC RHINOSINUSITIS TO DRIVE MARKET
7.5 SPHENOID SINUS SURGERY
7.5.1 HIGHER INDICATIONS FOR SURGERY TO BOOST ADOPTION
7.6 OTHER PROCEDURES
8 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY INDICATION
8.1 INTRODUCTION
8.2 FUNGAL SINUSITIS
8.2.1 RISING EXPOSURE TO FUNGAL SPORES TO DRIVE MARKET
8.3 CHRONIC SINUSITIS
8.3.1 GROWING PREVALENCE OF CRS TO SUPPORT MARKET GROWTH
8.4 NASAL POLYPOSIS
8.4.1 WIDE PREVALENCE OF CAUSATIVE/CONTRIBUTING FACTORS TO DRIVE MARKET
8.5 RECURRENT SINUSITIS
8.5.1 GROWING PREVALENCE OF COLD TO SUPPORT MARKET GROWTH
8.6 OTHER INDICATIONS
9 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PATIENT TYPE
9.1 INTRODUCTION
9.2 ADULT PATIENTS
9.2.1 ADULT PATIENTS TO DOMINATE MARKET FOR FESS
9.3 PEDIATRIC PATIENTS
9.3.1 HIGH PREVALENCE OF SINUSITIS IN CHILDREN TO DRIVE MARKET
10 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS & AMBULATORY SURGERY CENTERS
10.2.1 HOSPITALS & ASCS TO FORM LARGEST AND FASTEST-GROWING END-USER SEGMENT
10.3 SPECIALTY CLINICS
10.3.1 FASTER RECOVERY TIME AND COST-EFFECTIVENESS TO SUPPORT GROWTH
11 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US to dominate North American market
11.2.2 CANADA
11.2.2.1 Rising geriatric population and associated increase in prevalence of CRS to support market growth
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Germany to hold largest market share in Europe
11.3.2 UK
11.3.2.1 High R&D expenditure to drive market
11.3.3 FRANCE
11.3.3.1 High burden of chronic sinusitis to propel adoption of FESS
11.3.4 ITALY
11.3.4.1 Growing geriatric population to support adoption of FESS products
11.3.5 SPAIN
11.3.5.1 Rising healthcare expenditure to drive market for FESS
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 China to hold largest market share in APAC
11.4.2 JAPAN
11.4.2.1 Research initiatives to support market growth in Japan
11.4.3 INDIA
11.4.3.1 Increasing investments in research to support market growth
11.4.4 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 BRAZIL
11.5.1.1 Brazil to hold largest share of LATAM market till 2029
11.5.2 MEXICO
11.5.2.1 Rising geriatric population to support market growth
11.5.3 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 RISING HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH
11.7 GCC COUNTRIES
11.7.1 UAE
11.7.1.1 Growing number of hospitals to drive market
11.7.2 SAUDI ARABIA
11.7.2.1 Healthcare infrastructural improvements to support market growth
11.7.3 OTHER GCC COUNTRIES
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET
12.3 REVENUE ANALYSIS
12.4 MARKET SHARE ANALYSIS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Product footprint
12.5.5.3 Regional footprint
12.5.5.4 Procedure footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 VALUATION & FINANCIAL METRICS
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 MEDTRONIC PLC
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Deals
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 STRYKER CORPORATION
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 OLYMPUS CORPORATION
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product approvals
13.1.3.4 MnM view
13.1.3.4.1 Right to win
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses & competitive threats
13.1.4 B. BRAUN MELSUNGEN AG
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.5 KARL STORZ
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.6 CONMED CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.7 TELEFLEX INCORPORATED
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.8 INTEGRA LIFESCIENCES
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Deals
13.1.9 BRAINLAB AG
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 RUDOLF MEDICAL GMBH + CO. KG
13.1.10.1 Business overview
13.1.10.2 Products offered
13.2 OTHER PLAYERS
13.2.1 ATMOS MEDIZINTECHNIK
13.2.2 INNOVIA MEDICAL
13.2.3 SUTTER MEDIZINTECHNIK GMBH
13.2.4 RZ MEDIZINTECHNIK
13.2.5 ADVIN HEALTHCARE
13.2.6 ECLERIS
13.2.7 HENKE SASS WOLF
13.2.8 JEDMED
13.2.9 ENTERMED
13.2.10 FIAGON GMBH
13.2.11 CLARONAV KOLAHI INC.
13.2.12 ADEPT MEDICAL
13.2.13 MEDELEC SURGICAL
13.2.14 HEAL FORCE BIO-MEDITECH HOLDINGS LIMITED
13.2.15 COLLIN MEDICAL
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
